Taiwan · Delayed Price · Currency is TWD Orient EuroPharma Company Description
Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide.
Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs.
The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplements for liquid nutrition, regular blood lipids, l-arginines, agile movements, and improved sleep qualities under the Nutrifuel brand name.
In addition, the company offers dermo and cosmetic products under the Cumlaude Labs, AGLabs, Bio-Oil, and ISISPHARMAs brand names.
Further, it engages in the research and development of Multikine, an immunotherapy drug for head and neck cancer, which is in Phase III clinical study; NC-6004, a platinum-based micelle chemotherapeutic drug that is in Phase III clinical study; ASC-J9, a molecular chemical entity drug that has completed Phase IIb clinical study for androgen receptor degradation; and 2ccPA, a derivative of phospholipid to patients with symptomatic osteoarthritis of the knee, which is in Phase I clinical trial.
Orient EuroPharma Co., Ltd. was founded in 1982 and is based in Taipei, Taiwan.
| Country | Taiwan |
| Founded | 1982 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 339 |
| CEO | Mon-Lin Tsai |
Contact Details
Address: No. 128, Sec. 6, Chengde Rd. Taipei, 112 Taiwan | |
| Phone | 886 2 2755 4881 |
| Website | oepgroup.com |
Stock Details
| Ticker Symbol | 4120 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004120001 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Mon-Lin Tsai | Representative Director and GM |
| Jack Wang | Financial Officer and Accounting Officer |
| Liann Lai | Director of Human Resources and Administrative Division |
| Ming-Hsia Hung | Chief Audit Officer |
| Jack Wu | Director |